BackgroundEvidence regarding the efficacy or effectiveness of the disease-modifying drugs (DMDs) in the older multiple sclerosis (MS) population is scarce. This has contributed to a lack of evidence-b

NIAID Data Ecosystem40

Summary of histologic findings for placebo and tecovirimat treated NHPs that survived to end of study by tecovirimat treatment group.

药物疗效评估

非人灵长类病毒学

Summary of histologic findings for placebo and tecovirimat treated NHPs that survived to end of study by tecovirimat treatment group.

NIAID Data Ecosystem20

An overview of systematic reviews about ibuprofen and paracetamol for treating pain in children

疼痛治疗

药物疗效评估

Detailed characteristics of systematic reviews included in the overview of systematic reviews about ibuprofen and paracetamol for treating pain in children

Figshare2018-07-20 更新90

Induction ofsteatosis in primary human hepatocytes manifests into hepatic pathophysiology of metabolic dysfunction-associated liver disease. Induction ofsteatosis in primary human hepatocytes manifests into hepatic pathophysiology of metabolic dysfunction-associated liver disease

代谢性肝病

药物疗效评估

Background & Aims:The prevalence of metabolic dysfunction-associated liver disease (MASLD) has been strongly increasing over the last decades. As MASLD is often associated with more severe disease sta

NIAID Data Ecosystem20

Viral titer in different treatment schemes compared with the control without LOV group.

资源简介：

相关数据集